DIO Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

DIODie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -50.2% zurückgegangen, während in der Branche Medical Equipment die Gewinne wachsen. Die Umsätze sind gewachsen mit einer durchschnittlichen Rate von 4.8% pro Jahr.

Wichtige Informationen

-50.2%

Wachstumsrate der Gewinne

-50.3%

EPS-Wachstumsrate

Medical Equipment Wachstum der Industrie	22.7%
Wachstumsrate der Einnahmen	4.8%
Eigenkapitalrendite	-24.8%
Netto-Marge	-44.5%
Letzte Ertragsaktualisierung	30 Jun 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

We Think DIO (KOSDAQ:039840) Can Stay On Top Of Its Debt

May 03

An Intrinsic Calculation For DIO Corporation (KOSDAQ:039840) Suggests It's 43% Undervalued

Mar 18

What Type Of Shareholders Make Up DIO Corporation's (KOSDAQ:039840) Share Registry?

Mar 05

How Much Did DIO's(KOSDAQ:039840) Shareholders Earn From Share Price Movements Over The Last Year?

Jan 09

Is DIO Corporation's (KOSDAQ:039840) Stock Price Struggling As A Result Of Its Mixed Financials?

Dec 27

Should You Use DIO's (KOSDAQ:039840) Statutory Earnings To Analyse It?

Dec 09

Do Institutions Own DIO Corporation (KOSDAQ:039840) Shares?

Nov 27

Aufschlüsselung der Einnahmen und Ausgaben

Wie DIO Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

KOSDAQ:A039840 Einnahmen, Ausgaben und Erträge (KRW Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten	F&E-Ausgaben
30 Jun 24	121,262	-53,996	108,916	4,653
31 Mar 24	149,522	-3,797	77,554	3,615
31 Dec 23	155,818	3,311	78,223	3,834
30 Sep 23	149,128	-8,619	79,202	3,737
30 Jun 23	147,233	-10,529	81,687	3,975
31 Mar 23	137,948	-11,486	81,592	4,008
31 Dec 22	131,306	-20,458	81,155	3,898
30 Sep 22	146,583	7,784	76,924	3,421
30 Jun 22	147,461	15,121	70,113	3,270
31 Mar 22	150,618	20,377	65,252	3,046
31 Dec 21	150,037	28,255	62,008	2,780
30 Sep 21	146,007	25,733	53,943	2,605
30 Jun 21	135,782	20,255	48,767	2,276
31 Mar 21	123,976	16,222	45,120	2,135
31 Dec 20	120,056	11,153	44,900	1,980
30 Sep 20	121,120	10,047	50,748	2,368
30 Jun 20	123,795	14,227	52,610	2,480
31 Mar 20	128,284	20,348	54,140	2,509
31 Dec 19	127,165	21,732	53,074	2,827
30 Sep 19	111,987	16,856	53,710	3,448
30 Jun 19	103,759	12,087	51,808	3,296
31 Mar 19	95,823	5,043	48,913	3,384
31 Dec 18	91,043	5,455	46,951	2,820
30 Sep 18	92,510	6,233	38,416	2,454
30 Jun 18	93,946	9,320	37,257	1,928
31 Mar 18	95,257	13,286	36,858	2,436
31 Dec 17	91,918	8,559	34,728	2,570
30 Sep 17	88,201	19,935	34,896	2,542
30 Jun 17	87,651	18,839	33,242	2,514
31 Mar 17	87,133	19,480	29,330	2,310
31 Dec 16	88,020	20,514	26,738	2,228
30 Sep 16	90,638	17,526	22,418	2,012
30 Jun 16	84,794	16,672	19,843	2,012
31 Mar 16	78,580	11,523	18,447	1,678
31 Dec 15	71,939	9,252	17,584	1,581
30 Sep 15	65,964	8,223	18,009	1,090
30 Jun 15	64,052	3,939	20,943	1,090
31 Mar 15	60,988	-2,036	24,273	1,377
31 Dec 14	61,576	-3,610	26,786	1,441
30 Sep 14	65,834	-11,429	34,153	1,530
30 Jun 14	65,058	-12,642	33,062	1,530
31 Mar 14	65,768	-8,819	31,164	1,713
31 Dec 13	62,795	-8,271	29,435	1,961

Qualität der Erträge: A039840 ist derzeit unrentabel.

Wachsende Gewinnspanne: A039840 ist derzeit unrentabel.

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: A039840 ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 50.2% pro Jahr zugenommen.

Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von A039840 verglichen werden, da das Unternehmen derzeit nicht profitabel ist.

Erträge im Vergleich zur Industrie: A039840 ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Medical Equipment (3.1%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: A039840 hat eine negative Eigenkapitalrendite (-24.8%), da es derzeit unrentabel ist.

DIO Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Second quarter 2024 earnings released: ₩3,259 loss per share (vs ₩197 profit in 2Q 2023)

Full year 2023 earnings released: EPS: ₩227 (vs ₩1,380 loss in FY 2022)

Full year 2022 earnings: EPS and revenues miss analyst expectations

Third quarter 2021 earnings released: EPS ₩602 (vs ₩232 in 3Q 2020)

Third quarter 2021 earnings released: EPS ₩602 (vs ₩232 in 3Q 2020)

First quarter 2021 earnings released: EPS ₩704 (vs ₩349 in 1Q 2020)

Recent updates

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: ₩3,259 loss per share (vs ₩197 profit in 2Q 2023)

Consensus revenue estimates fall by 20%

DIO Corporation (KOSDAQ:A039840) announces an Equity Buyback for KRW 10,000 million worth of its shares.

Consensus revenue estimates fall by 17%

Price target decreased by 8.2% to ₩33,750

Consensus EPS estimates increase by 15%

Full year 2023 earnings released: EPS: ₩227 (vs ₩1,380 loss in FY 2022)

New major risk - Revenue and earnings growth

DIO Corporation announced that it expects to receive KRW 85 billion in funding from H Private Equity Co., Ltd.

DIO Corporation announced that it expects to receive KRW 85 billion in funding from H Private Equity Co., Ltd.

Price target decreased by 10% to ₩38,200

Now 24% undervalued after recent price drop

Now 21% undervalued after recent price drop

Full year 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment improved over the past week

Less than half of directors are independent

DIO Corporation (KOSDAQ:A039840) announces an Equity Buyback for KRW 3,000 million worth of its shares.

Consensus revenue estimates fall by 12%

Investor sentiment deteriorated over the past week

Price target decreased to ₩53,500

Less than half of directors are independent

Price target decreased to ₩54,200

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₩602 (vs ₩232 in 3Q 2020)

Third quarter 2021 earnings released: EPS ₩602 (vs ₩232 in 3Q 2020)

Price target increased to ₩58,200

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ₩704 (vs ₩349 in 1Q 2020)

We Think DIO (KOSDAQ:039840) Can Stay On Top Of Its Debt

Consensus forecasts updated

An Intrinsic Calculation For DIO Corporation (KOSDAQ:039840) Suggests It's 43% Undervalued

What Type Of Shareholders Make Up DIO Corporation's (KOSDAQ:039840) Share Registry?

Full year 2020 earnings released: EPS ₩758 (vs ₩1,483 in FY 2019)

Has DIO (KOSDAQ:039840) Got What It Takes To Become A Multi-Bagger?

New 90-day high: ₩40,650

What Does DIO Corporation's (KOSDAQ:039840) Share Price Indicate?

Price target raised to ₩43,500

Investor sentiment improved over the past week

New 90-day high: ₩35,250

DIO (KOSDAQ:039840) Seems To Use Debt Quite Sensibly

How Much Did DIO's(KOSDAQ:039840) Shareholders Earn From Share Price Movements Over The Last Year?

New 90-day high: ₩33,850

Is DIO Corporation's (KOSDAQ:039840) Stock Price Struggling As A Result Of Its Mixed Financials?

Should You Use DIO's (KOSDAQ:039840) Statutory Earnings To Analyse It?

Do Institutions Own DIO Corporation (KOSDAQ:039840) Shares?

Analysts lower EPS estimates to ₩1,346

New 90-day high: ₩32,950

Third quarter 2020 earnings released: EPS ₩232

New 90-day high: ₩31,550

New 90-day high: ₩29,800

Price target lowered to ₩32,438

Aufschlüsselung der Einnahmen und Ausgaben

Gewinn- und Umsatzhistorie

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Eigenkapitalrendite

Kapitalrendite

Rendite auf das eingesetzte Kapital

Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren